INTERNATIONAL PATENT: DEUTSCHES KREBSFORSCHUNGSZENTRUM STIFTUNG DES OEFFENTLICHEN RECHTS FILES APPLICATION FOR "PHARMACEUTICAL COMBINATION PRODUCT COMPRISING KINASE INHIBITOR AND AUTOPHAGY INDUCER AND USES THEREOF"

GENEVA, March 24 -- DEUTSCHES KREBSFORSCHUNGSZENTRUM STIFTUNG DES OEFFENTLICHEN RECHTS (Im Neuenheimer Feld 28069120 Heidelberg) filed a patent application (PCT/EP2024/075359) for "PHARMACEUTICAL COMBINATION PRODUCT COMPRISING KINASE INHIBITOR AND AUTOPHAGY INDUCER AND USES THEREOF" on Sep 11, 2024. With publication no. WO/2025/056601, the details related to the patent application was published on Mar 20, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): PENA-LLOPIS, Samuel (Deutsches Krebsforschungszentrum Stiftung des offentlicheen Rechts Innovation-ManagementIm Neuenheimer Feld 28069120 Hei...